News from merz pharmaceuticals, llc

Feb 21, 2013, 10:24 ET

Mederma® Wear Your Skin Proudly™ Survey Reveals Men and Women have Complex and Often Differing Feelings about how their Skin Imperfections Impact their Appearance and Confidence

Mederma® today announced the results of the second Mederma® Wear Your Skin Proudly™ survey, conducted by Harris Interactive, which...

Apr 23, 2012, 08:01 ET

XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 64th Annual Meeting of the American Academy of Neurology

Merz Pharmaceuticals today announced that initial baseline data from an ongoing Phase 4 Trial Evaluating XEOMIN® (incobotulinumtoxinA) for...

Apr 14, 2011, 08:11 ET

Merz Pharmaceuticals Joins Patient Advocates to Raise Awareness of Cervical Dystonia and Blepharospasm

Merz Pharmaceuticals, LLC, maker of XEOMIN® (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, today announced the...

Mar 30, 2011, 08:11 ET

Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)

Merz Pharmaceuticals, LLC announced today that the Centers for Medicare and Medicaid Services (CMS) has granted a unique Healthcare Common...

Jan 25, 2011, 09:00 ET

New Survey Finds That, Despite Having Stretch Marks and Scars, Women of All Ages Maintain Their Ability to Wear Their Skin Proudly!

Mederma®, the doctor- and pharmacist-recommended brand for stretch marks and scars, today announced the results of the inaugural Wear Your...

Aug 02, 2010, 08:11 ET

FDA Approves Merz Pharmaceuticals' Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm

Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin®...

Feb 17, 2010, 10:15 ET

Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide

Stretch marks can make even the most beautiful women feel insecure and self-conscious. Approximately 90% of pregnant women and 70% of adolescent...

Sep 15, 2009, 09:00 ET

Merz Pharmaceuticals' Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA

Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...

Sep 11, 2009, 09:55 ET

Merz Pharmaceuticals' Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA

Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...

Nov 12, 2002, 00:00 ET

Beauty Category Growth May Cause Consumer Confusion; Aqua Glycolic(R) Answers the Need for Quality, Convenience and Safety

GREENSBORO, N.C., Nov. 12 /PRNewswire/ -- According to the 2002 Household & Personal Products Industry report, consumers spent a total of 37...

Nov 12, 2002, 00:00 ET

Finally! Beautiful Nails Without the Fuss New Oral Nail Treatment From Merz Pharmaceuticals Offers a Simple Solution to Consumers

GREENSBORO, N.C., Nov. 12 /PRNewswire/ -- Without fail, it always happens when you want to look your best -- a job interview, a first date -- a...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer